Trials / Terminated
TerminatedNCT04073485
Microwave Ablation for Uterine Fibroids
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to evaluate the clinical safety and effectiveness of Microwave ablation (MWA) in treating patients with uterine fibroid.
Detailed description
Percutaneous radiofrequency ablation (RFA) is another form of thermal ablation that has been used for the treatment of uterine fibroids. Although RFA is more invasive when compared to High-Intensity-Focused-Ultrasound (HIFU), the treatment is less limited by the location of the lesions, and the treatment procedure is more time efficient. To further improve the technology of thermal ablation for uterine fibroid, percutaneous microwave ablation (MWA) could be a promising option because it allows increased efficiency of energy transmission and reduction in procedure time, and may allow effective treatment of large lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Microwave ablation | Ultrasonogram is performed to identify the fibroid or adenomyoma. A trocar needle is placed into the lesion under local anesthesia. The MWA procedure is performed using appropriate microwave power and application time are selected to provide sufficient ablation coverage to the target lesion. |
Timeline
- Start date
- 2019-09-05
- Primary completion
- 2023-03-09
- Completion
- 2023-03-31
- First posted
- 2019-08-29
- Last updated
- 2023-05-03
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04073485. Inclusion in this directory is not an endorsement.